Routine pelvic examination for asymptomatic women: Exploring the evidence

Australian Family Physician

Volumn 35, Issue 11, 2006, Pages 873-876

  Stewart, Rebecca Anne ^a   Thistlethwaite, Jill ^b  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; FEMALE; HUMAN; INFORMED CONSENT; MASS SCREENING; OVARY TUMOR; PALPATION; PHYSICAL EXAMINATION; REVIEW; UTERUS CANCER; VAGINA SMEAR;

ADULT; FEMALE; HUMANS; INFORMED CONSENT; MASS SCREENING; OVARIAN NEOPLASMS; PALPATION; PHYSICAL EXAMINATION; UTERINE NEOPLASMS; VAGINAL SMEARS;

EID: 34247567497     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Carney P, Dietrich A, Freeman D, Mott L. The periodic health examination provided to asymptomatic older women. Ann Intern Med 1993;119:129-35.
2. Frye C, Weisberg R. Increasing the incidence of routine pelvic examinations: behavioural medicine's contribution. Women Health 1994;21:33-55.
3. Gupta S, Hogan R, Kirkman RJE. Experience of the first pelvic examination. Eur J Contracept Reprod Health Care 2001;6:34-8.
4. Ferrini R. Screening asymptomatic women for ovarian cancer: American College of Preventive Medicine, Practice Policy Statement. Am J Prev Med 1997;13:444-6.
5. National Institute of Health. Consensus Statement Online. Ovarian cancer: screening, treatment and follow up. NIH, 1994;12:1-30.
6. US Preventive Services Task Force. Recommendations on ovarian cancer screening, guide to clinical preventive services. 2nd ed. Rockville: AHRQ, 1996.
7. National Cancer Institute. Ovarian Cancer Research Results from the Prostate, Lung and Ovarian (PCLO) Cancer Screening Trial: fact sheet. Bethesda: NCI, July 2005.
8. Runowicz C. Ovarian cancer screening. In: New York State Department of Health, genetic susceptibility to breast and ovarian cancer: assessment, counselling and testing guidelines. Appendix VI. New York: New York State DOH, October 1999.
9. Padilla L, Radosevich D, Milad M. Limitations of the pelvic examination for evaluation of the female pelvic organs. Int J Gynecol Obstet 2005;88:84-8.
10. Gladstone C. Screening for ovarian cancer. In: Canadian Task Force on the Periodic Health Examination. Canadian guide to clinical preventive health care. Ottawa: Health Canada, 1994;870-80.
11. NLH Primary Care Question Answering Service. Is there any guideline available regarding whether pelvic examination should be done simultaneously when women have their routine three yearly cervical smear? How useful is this type of examination as a screening tool? Available at www. clinicalanswers.nhs.uk/ [Accessed July 2006].
12. Grover S, Quinn M. Is there any value in bimanual pelvic examination as a screening test?. Med J Aust 1995;162:396.
13. Schachter J, Schafer M, Young M, Ott M. Routine pelvic examinations in asymptomatic young women. New Engl J Med 1996;334:1847-8.
14. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Position statement: Screening for the prevention of cervical cancer. Melbourne: RANZCOG, 2004.
15. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Position statement: Guidelines for gynaecological examinations and procedures. Melbourne: RANZCOG, 2004.
16. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Position statement: Joint guidelines on Pap smears. Melbourne: RANZCOG, 2004.
17. Scott A, Glasier A. Are routine breast and pelvic examinations necessary for women starting combined oral contraception?. Hum Reprod Update 2004;10:449-52.
18. Harrison-Woolrych M, Purdie D. Breast and pelvic examination in women taking hormone replacement therapy. Br J Obstet Gynaecol 2001;108:1201-3.
19. Sivanesaratnam V. Gynecological cancer screening. Ann Acad Med Singapore 1989;18:75-9.